Link to this page
Physician Data Query
Preferred Name | thymopentin | |
Synonyms |
Timunox N-(N-(N-(N(2)-L-Arginyl-L-Lysyl)-L-alpha-Aspartyl)-L-Valyl)-L-tyrosine Mepentil Immunox Sintomodulina |
|
Definitions |
A synthetic pentapeptide which is the active site of the naturally occurring hormone thymopoietin with immunomodulating properties. Thymopentin enhances the production of thymic T cells and may help restore immunocompetence in immunosuppressed subjects. This agent also augments the effects of ionizing radiation by arresting cancer cells in the G2/M phase of the cell cycle. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1294" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1294" NCI Thesaurus) |
|
ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000041655 |
|
altLabel |
Timunox N-(N-(N-(N(2)-L-Arginyl-L-Lysyl)-L-alpha-Aspartyl)-L-Valyl)-L-tyrosine Mepentil Immunox Sintomodulina
|
|
CAS Registry |
69558-55-0
|
|
cui |
C0918006 C1515435 C1515436 C0080225 C1831597
|
|
definition |
A synthetic pentapeptide which is the active site of the naturally occurring hormone thymopoietin with immunomodulating properties. Thymopentin enhances the production of thymic T cells and may help restore immunocompetence in immunosuppressed subjects. This agent also augments the effects of ionizing radiation by arresting cancer cells in the G2/M phase of the cell cycle. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1294" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1294" NCI Thesaurus)
|
|
IND Code |
39678
|
|
Legacy PDQ ID |
4817
|
|
LT |
TRD
|
|
NCI ID |
C1294
|
|
notation |
CDR0000041655
|
|
NSC Code |
645363
|
|
ORIG STY |
Drug/agent
|
|
prefLabel |
thymopentin
|
|
tui |
T116 T123 T121
|
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |